- GlobeNewswire•13 hours agoNew Analysis of Reverse Trial Shows Medtronic CRT Devices Cost-Effective, While Helping Patients with Mild Heart Failure Live Longer
JACC: HF Study Showcases Economic Value of Earlier Patient Access to Cardiac Resynchronization Therapy DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year ...
- GlobeNewswire•16 hours ago
DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37 th Annual Cowen and Company Healthcare Conference on Tuesday, ...
- Investopedia•4 days ago
Boston Scientific is recalling its Lotus heart devices, citing a manufacturing defect.
MDT : Summary for Medtronic plc. Ordinary Shares - Yahoo Finance
Medtronic plc (MDT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||80.65 - 81.16|
|52 Week Range||69.35 - 89.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||26.89|
|Dividend & Yield||1.72 (2.12%)|
|1y Target Est||N/A|